Citadel Advisors
ALIM

Citadel Advisors’s Alimera Sciences ALIM Stock Holding History

Citadel Advisors’s Portfolio ALIM Stock Details ALIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-28,871
Closed -$113K – 15704
2024
Q1 		$113K Buy
28,871
+8,997
+45% +$34.2K ﹤0.01% 11191
2023
Q4 		$85.9K Buy
+19,874
New +$67.1K ﹤0.01% 11126
2022
Q3 		– Sell
-14,402
Closed -$79K – 13844
2022
Q2 		$79K Buy
+14,402
New +$79.2K ﹤0.01% 11605
2021
Q2 		– Sell
-10,402
Closed -$100K – 14613
2021
Q1 		$100K Buy
+10,402
New +$85.2K ﹤0.01% 12478
2019
Q4 		– Sell
-5,742
Closed -$49K – 9908
2019
Q3 		$49K Buy
+5,742
New +$52.2K ﹤0.01% 8714
2019
Q2 		– Sell
-6,089
Closed -$97K – 10009
2019
Q1 		$97K Buy
+6,089
New +$92.6K ﹤0.01% 8573
2018
Q2 		– Sell
-2,709
Closed -$42K – 9396
2018
Q1 		$42K Sell
2,709
-911
-25% -$16.2K ﹤0.01% 7979
2017
Q4 		$72K Buy
3,620
+2,824
+355% +$55.1K ﹤0.01% 7530
2017
Q3 		$16K Sell
796
-1,492
-65% -$31.9K ﹤0.01% 7399
2017
Q2 		$48K Buy
+2,288
New +$49K ﹤0.01% 7100
2015
Q2 		– Sell
-198
Closed -$15K – 9165
2015
Q1 		$15K Sell
198
-956
-83% -$75.2K ﹤0.01% 8071
2014
Q4 		$96K Buy
1,154
+1,087
+1,622% +$88.2K ﹤0.01% 6672
2014
Q3 		$5K Sell
67
-504
-88% -$43K ﹤0.01% 7927
2014
Q2 		$51K Sell
571
-225
-28% -$20K ﹤0.01% 6726
2014
Q1 		$94K Buy
+796
New +$77.3K ﹤0.01% 6262

Other funds holding ALIM

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Citadel Advisors's ALIM Position: Q2 2024 in Review

Citadel Advisors sold out of Alimera Sciences (ALIM) in Q2 2024, closing a stake of 28,871 shares — an estimated $113K sold.

Citadel Advisors first reported a position in ALIM in Q1 2014 and held it in 15 quarters. The position peaked at $113K in Q1 2024. 52 funds tracked by Wall St. Rank hold ALIM as of Q2 2024.

  • Citadel Advisors reported no remaining Alimera Sciences position as of Q2 2024 after selling out during the quarter.
  • Citadel Advisors sold 28,871 Alimera Sciences shares in Q2 2024, an estimated $113K.
  • Citadel Advisors first reported a position in Alimera Sciences in Q1 2014 and held it in 15 quarters.
  • Citadel Advisors's Alimera Sciences position peaked at $113K in Q1 2024.
  • 52 funds tracked by Wall St. Rank held Alimera Sciences as of Q2 2024.

Based on Citadel Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.